• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

70.0100 EUR 0.4300 0.61%

As of 11:35:00 ET on 01/27/2015.

Snapshot for UCB SA (UCB)

Open: 70.5000 Day's Range: 69.6000 - 71.5000 Volume: 184,339
Previous Close: 70.4400 52wk Range: 50.1100 - 75.6200 1-Yr Rtn: +36.15%

Stock Chart for UCB

No chart data available.
  • UCB:BB 70.0100
  • 1D
  • 1M
  • 1Y
70.4400
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) 52.2463
Estimated P/E(12/2014) 33.7886
Relative P/E vs. BEL20 1.2556
Earnings Per Share (EUR) (ttm) 1.3400
Est. EPS (EUR) (12/2014) 2.0720
Est. PEG Ratio 1.9905
Market Cap (M EUR) 13,617.34
Shares Outstanding (M) 194.51
30 Day Average Volume 284,130
Price/Book (mrq) 2.8310
Price/Sale (ttm) 4.1468
Dividend Indicated Gross Yield 1.49%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth 2.48%
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Jean-Christophe TellierChief Executive OfficerDetlef ThielgenExec VP/CFO
Ismail KolaExec VP/Pres:NewmedicinesAnna S RichoExec VP/General Counsel
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil